Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Systemic sclerosis]

R Gustafsson1

  • 1Reumatologiska kliniken, Karolinska sjukhuset, Stockholm.

Nordisk Medicin
|January 1, 1994
PubMed
Summary
This summary is machine-generated.

Systemic sclerosis is a connective tissue disease causing skin thickening and internal organ damage. Accurate patient subset assignment is crucial for managing this condition due to the lack of adequate therapies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Epstein-Barr virus infection after adolescence and human herpesvirus 6A as risk factors for multiple sclerosis.

European journal of neurology·2020
Same author

Phenotypic and functional activation of alveolar macrophages, T lymphocytes and NK cells in patients with systemic sclerosis and primary Sjögren's syndrome.

Annals of the rheumatic diseases·1994
Same author

Short-term kinetics of the humoral anti-C1q response in SLE using the ELISPOT method: fast decline in production in response to steroids.

Scandinavian journal of immunology·1994
Same author

Non-invasive evaluation of long-term cardiac effects of captopril in systemic sclerosis.

Journal of internal medicine·1991
Same author

Eosinophil activation in systemic sclerosis.

Arthritis and rheumatism·1991
Same author

Non-invasive assessment of systolic left ventricular function in systemic sclerosis.

European heart journal·1991
Same journal

[Nordisk Medicine 1929-1998. Thanks and farewell!].

Nordisk medicin·1999
Same journal

[Scientific fraud and misconduct--need for comprehensive terminology].

Nordisk medicin·1999
Same journal

[Labor-market for Scandinavian physicians in the year 2000--dearth or surplus?].

Nordisk medicin·1999
Same journal

[Internet in consultation--headed for trouble?].

Nordisk medicin·1999
Same journal

[Interpretation of questionnaires. An translation method problem].

Nordisk medicin·1999
Same journal

[Assessment of patients' health status--review of the literature and assessment methods].

Nordisk medicin·1999
See all related articles

Area of Science:

  • Rheumatology
  • Immunology
  • Dermatology

Context:

  • Systemic sclerosis is a complex autoimmune disease affecting connective tissues.
  • Etiology remains unknown, but silica exposure is a potential risk factor.
  • Pathogenesis involves vascular, immunological, and fibroblast dysfunction.

Purpose:

  • To elucidate the characteristics and subsets of systemic sclerosis.
  • To highlight the importance of subset classification for patient management.
  • To underscore the need for improved therapeutic strategies.

Summary:

  • Systemic sclerosis presents with skin thickening and fibrosis, potentially affecting internal organs like kidneys, lungs, and heart.
  • Two main subsets exist: limited cutaneous and diffuse cutaneous scleroderma, with the latter having a poorer prognosis.

Related Experiment Videos

  • Current management lacks adequate therapies, emphasizing the need for precise subset assignment to guide treatment based on disease stage and functional changes.

    • Impact:

    • Improved understanding of systemic sclerosis subsets can lead to more tailored patient care.
    • Highlights the critical need for further research into effective treatments.
    • Accurate classification aids in prognostication and resource allocation for patient management.